Hikma Is Taking Another Look At US Biosimilars

CEO Siggi Olafsson Reveals Firm Is Considering US Partnerships

 
• By Dave Wallace

Hikma CEO Siggi Olafsson has outlined the potential future opportunity that the firm sees in the US biosimilars market, in the second part of an exclusive interview with Generics Bulletin.

US USA Flag Shake Hands Handshake
Hikma could be a “great partner” on US biosimilars, Olafsson believes • Source: Shutterstock

More from Strategy

More from Business